Sample management has become increasingly important in every phase of chemical and biological discovery. Control over factors like sample quality, process efficiency, metadata and miniaturization must be achieved to accelerate both academic and industrial programs. Further complexity arises in maintaining these factors when collaborating with an external research partner. The SLAS 2020 European Sample Management Symposium welcomes all compound and sample management professionals – from bench scientists to senior leaders – to obtain fresh perspectives and share innovative solutions to challenges in these domains.
The 2020 program will focus on these key areas:
Supply Chain Management
Compound management, and modern experimental life sciences as a whole, critically depend on consumables and solvents. In this session, we want to learn more about the supply chain of these products. Most end users may be unaware of the challenges and efforts it takes to reliably deliver high-quality consumable products - as long as the supply chain works well.
Due to the rise in novel technologies in drug discovery, sample collections beyond the classical pharmaceutical or academic standard small molecules are gaining attention. Management of biomolecules such as antibodies, peptides or nucleic acids, as well as collections for alternative therapeutic approaches such as DNA encoded libraries, PROTACs, or natural products, requires tailored operating procedures which are less well standardized. In this session, speakers from academia and industry will present case studies about the management of such non-standard sample collections.
We have undoubtedly entered an era where data and software rule. New concepts such as the blockchain appear to have disruptive potential. In this session, we will discuss what this means for Sample Management. Can we expect an evolution, or should we brace for revolution?
Historically, laboratory automation was used mostly to scale up repetitive tasks. Recent developments make it possible to expand the scope of automation and digital laboratory solutions to encompass more complex processes, peripheral work and experimental design and execution. Here, we consider how device, augmented and digital innovations could impact the way we work?
The interactive session is a great opportunity to pick up the topics that interest you and discuss them with the audience and expert panel. Use the opportunity to put your interests on the agenda!
Benefits to attendees include: